• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过嗜性修饰的腺病毒载体对Smad1的Hoxc-8相互作用结构域进行体外转移,可在兔脊柱融合模型中有效促进骨形成。

Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.

作者信息

Douglas Joanne T, Rivera Angel A, Lyons Gray R, Lott Patricia F, Wang Dezhi, Zayzafoon Majd, Siegal Gene P, Cao Xu, Theiss Steven M

机构信息

Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

J Spinal Disord Tech. 2010 Feb;23(1):63-73. doi: 10.1097/BSD.0b013e318193b693.

DOI:10.1097/BSD.0b013e318193b693
PMID:20084034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2819464/
Abstract

STUDY DESIGN

Ex vivo gene transfer for spinal fusion.

OBJECTIVE

This study aimed to evaluate ex vivo transfer of the nuclear-localized Hoxc-8-interacting domain of Smad1 (termed Smad1C) to rabbit bone marrow stromal cells (BMSCs) by a tropism-modified human adenovirus serotype 5 (Ad5) vector as a novel therapeutic approach for spinal fusion.

SUMMARY OF BACKGROUND DATA

Novel approaches are needed to improve the success of bone union after spinal fusion. One such approach is the ex vivo transfer of a gene encoding an osteoinductive factor to BMSCs which are subsequently reimplanted into the host. We have previously shown that heterologous expression of the Hoxc-8-interacting domain of Smad1 in the nuclei of osteoblast precursor cells is able to stimulate the expression of genes related to osteoblast differentiation and induce osteogenesis in vivo. Gene delivery vehicles based on human Ad5 are well suited for gene transfer for spinal fusion because they can mediate high-level, short-term gene expression. However, Ad5-based vectors with native tropism poorly transduce BMSCs, necessitating the use of vectors with modified tropism to achieve efficient gene transfer.

METHODS

The gene encoding Smad1C was transferred to rabbit BMSCs by an Ad5 vector with native tropism or a vector retargeted to alphav integrins, which are abundantly expressed on rabbit BMSCs. Transduced BMSCs were maintained in osteoblastic differentiation medium for 30 days. Alkaline phosphatase activity was determined and cells stained for calcium deposition. As positive controls for osteogenesis, we used Ad5 vectors expressing bone morphogenetic protein 2. As negative controls, BMSCs were mock-transduced or transduced with an Ad5 vector expressing beta-galactosidase. In an immunocompetent rabbit model of spinal fusion, transduced BMSCs were coated onto absorbable gelatin sponge and implanted between decorticated transverse processes L6 and L7 of 8-week-old female New Zealand white rabbits. Animals were killed 4 weeks after implantation of the sponges, the fusion masses harvested and the area of new bone quantified using image analysis software.

RESULTS

The Smad1C-expressing tropism-modified Ad5 vector mediated a significantly higher level of alkaline phosphatase activity and calcium deposition in transduced rabbit BMSCs than all other vectors. The rabbit BMSCs transduced ex vivo with the Smad1C-expressing tropism-modified Ad5 vector mediated a greater amount of new bone formation than BMSCs transduced with any other vector.

CONCLUSIONS

Delivery of the Smad1C gene construct to BMSCs by an alphav integrin-targeted Ad5 vector shows promise for spinal fusion and other applications requiring the formation of new bone in vivo.

摘要

研究设计

用于脊柱融合的体外基因转移。

目的

本研究旨在评估通过嗜性修饰的人5型腺病毒(Ad5)载体将Smad1的核定位Hoxc-8相互作用结构域(称为Smad1C)体外转移至兔骨髓基质细胞(BMSC),作为脊柱融合的一种新型治疗方法。

背景数据总结

需要新的方法来提高脊柱融合后骨愈合的成功率。一种这样的方法是将编码骨诱导因子的基因体外转移至BMSC,随后将其重新植入宿主。我们之前已经表明,Smad1的Hoxc-8相互作用结构域在成骨细胞前体细胞的细胞核中的异源表达能够刺激与成骨细胞分化相关的基因表达,并在体内诱导成骨。基于人Ad5的基因递送载体非常适合用于脊柱融合的基因转移,因为它们可以介导高水平的短期基因表达。然而,具有天然嗜性的基于Ad5的载体很难转导BMSC,因此需要使用具有修饰嗜性的载体来实现有效的基因转移。

方法

通过具有天然嗜性的Ad5载体或重新靶向αv整合素(在兔BMSC上大量表达)的载体,将编码Smad1C的基因转移至兔BMSC。转导的BMSC在成骨细胞分化培养基中培养30天。测定碱性磷酸酶活性,并对细胞进行钙沉积染色。作为成骨的阳性对照,我们使用表达骨形态发生蛋白2的Ad5载体。作为阴性对照,BMSC进行模拟转导或用表达β-半乳糖苷酶的Ad5载体转导。在具有免疫活性的兔脊柱融合模型中,将转导的BMSC包被在可吸收明胶海绵上,并植入8周龄雌性新西兰白兔的L6和L7去皮质横突之间。在植入海绵4周后处死动物,收获融合块,并用图像分析软件对新骨面积进行定量。

结果

表达Smad1C的嗜性修饰Ad5载体介导转导的兔BMSC中的碱性磷酸酶活性和钙沉积水平显著高于所有其他载体。用表达Smad1C的嗜性修饰Ad5载体体外转导的兔BMSC介导的新骨形成量比用任何其他载体转导的BMSC都多。

结论

通过靶向αv整合素的Ad5载体将Smad1C基因构建体递送至BMSC,在脊柱融合和其他需要在体内形成新骨的应用中显示出前景。

相似文献

1
Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.通过嗜性修饰的腺病毒载体对Smad1的Hoxc-8相互作用结构域进行体外转移,可在兔脊柱融合模型中有效促进骨形成。
J Spinal Disord Tech. 2010 Feb;23(1):63-73. doi: 10.1097/BSD.0b013e318193b693.
2
Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials.采用体外复制缺陷型腺病毒介导的骨形态发生蛋白-2 基因转染骨髓基质细胞和复合生物材料进行大规模双皮质颅骨骨再生。
Neurosurgery. 2009 Dec;65(6 Suppl):75-81; discussion 81-3. doi: 10.1227/01.NEU.0000345947.33730.91.
3
Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA.克服免疫反应以允许通过人5型腺病毒递送LIM矿化蛋白-1 cDNA进行脊柱融合的离体基因治疗。
Spine (Phila Pa 1976). 2003 Feb 1;28(3):219-26. doi: 10.1097/01.BRS.0000042417.37236.3F.
4
Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.嵌合腺病毒载体的使用可增强骨形态发生蛋白2(BMP2)的产生及骨形成。
Hum Gene Ther. 2002 Jul 20;13(11):1337-47. doi: 10.1089/104303402760128568.
5
In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.使用携带人骨形态发生蛋白-2基因的重组腺病毒载体在体外和体内诱导骨形成。
Calcif Tissue Int. 2001 Feb;68(2):87-94.
6
The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.用产生骨形态发生蛋白-2的骨髓细胞进行慢病毒基因治疗对大鼠脊柱融合的影响。
J Spinal Disord Tech. 2008 Jul;21(5):372-9. doi: 10.1097/BSD.0b013e31814cf51d.
7
Ex vivo bone morphogenetic protein-2 gene delivery using bone marrow stem cells in rabbit maxillary sinus augmentation in conjunction with implant placement.兔上颌窦提升术中应用骨髓基质干细胞携带骨形态发生蛋白-2 基因的体外实验研究。
J Periodontol. 2013 Jul;84(7):985-94. doi: 10.1902/jop.2012.120221. Epub 2012 Aug 16.
8
Molecules mimicking Smad1 interacting with Hox stimulate bone formation.模拟与Hox相互作用的Smad1的分子刺激骨形成。
J Biol Chem. 2004 Mar 19;279(12):11313-9. doi: 10.1074/jbc.M312731200. Epub 2003 Dec 12.
9
Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord.腺病毒载体介导的脑源性神经营养因子对骨髓基质细胞的离体基因转移促进了在完全横断的成年大鼠脊髓移植后轴突的再生。
Eur Spine J. 2007 Dec;16(12):2206-14. doi: 10.1007/s00586-007-0499-3. Epub 2007 Sep 21.
10
Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.慢病毒和腺病毒基因疗法对大鼠脊柱融合作用的比较。
Spine (Phila Pa 1976). 2008 Jun 1;33(13):1410-7. doi: 10.1097/BRS.0b013e3181761003.

引用本文的文献

1
Clinical and radiological outcomes of a cervical cage with integrated fixation.具有一体化固定功能的颈椎椎间融合器的临床及影像学结果
Medicine (Baltimore). 2019 Jan;98(3):e14097. doi: 10.1097/MD.0000000000014097.
2
The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease.脊柱退行性疾病的脊柱融合的生物学增强。
Int J Mol Sci. 2018 Aug 17;19(8):2430. doi: 10.3390/ijms19082430.
3
Mesenchymal Stem Cells for the Treatment of Spinal Arthrodesis: From Preclinical Research to Clinical Scenario.间充质干细胞用于治疗脊柱融合术:从临床前研究到临床应用

本文引用的文献

1
Adenoviral vectors for gene therapy.用于基因治疗的腺病毒载体。
Mol Biotechnol. 2007 May;36(1):71-80. doi: 10.1007/s12033-007-0021-5.
2
Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.转染纤维突变型腺病毒BMP2基因的间充质干细胞增强骨诱导作用。
J Gene Med. 2005 Oct;7(10):1322-34. doi: 10.1002/jgm.777.
3
Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression.钙调蛋白和钙调蛋白依赖性激酶IIα通过控制c-fos表达来调节成骨细胞分化。
Stem Cells Int. 2017;2017:3537094. doi: 10.1155/2017/3537094. Epub 2017 Feb 13.
4
Spinal fusion in the next generation: gene and cell therapy approaches.下一代脊柱融合术:基因与细胞治疗方法
ScientificWorldJournal. 2014 Jan 28;2014:406159. doi: 10.1155/2014/406159. eCollection 2014.
J Biol Chem. 2005 Feb 25;280(8):7049-59. doi: 10.1074/jbc.M412680200. Epub 2004 Dec 7.
4
Spine fusion by gene therapy.基因疗法实现脊柱融合。
Gene Ther. 2004 Feb;11(4):360-7. doi: 10.1038/sj.gt.3302203.
5
Molecules mimicking Smad1 interacting with Hox stimulate bone formation.模拟与Hox相互作用的Smad1的分子刺激骨形成。
J Biol Chem. 2004 Mar 19;279(12):11313-9. doi: 10.1074/jbc.M312731200. Epub 2003 Dec 12.
6
BMPs and gene therapy for spinal fusion: summary statement.骨形态发生蛋白与脊柱融合的基因治疗:总结声明。
Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S85. doi: 10.1097/01.BRS.0000076903.10966.86.
7
Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique.使用微创基因治疗技术的胸腔镜下椎间盘内脊柱融合术。
J Bone Joint Surg Am. 2003 May;85(5):866-71. doi: 10.2106/00004623-200305000-00014.
8
Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector.纤维突变腺病毒载体介导的BMP2基因高效转移及间充质干细胞的骨形成
Mol Ther. 2003 Mar;7(3):354-65. doi: 10.1016/s1525-0016(02)00062-x.
9
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.重组人骨形态发生蛋白-2在脊柱融合术应用中的使用
Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S66-85. doi: 10.1097/00007632-200208151-00014.
10
Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion.重组人骨生成蛋白-1(骨形态发生蛋白-7)作为脊柱融合术中的骨诱导剂。
Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S59-65. doi: 10.1097/00007632-200208151-00013.